scispace - formally typeset
Search or ask a question

Showing papers by "Jaishree Jagirdar published in 2012"

Journal Article•DOI•
Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.

[...]

Bradley M. Turner1, Philip T. Cagle, Irma M. Sainz2, Junya Fukuoka3, Steven S. Shen, Jaishree Jagirdar1 •
University of Texas Health Science Center at San Antonio1, Memorial Hospital of South Bend2, University of Toyama3
30 Jan 2012-Archives of Pathology & Laboratory Medicine
TL;DR: Nap-A is superior to TTF-1 in distinguishing primary lung ACA from other carcinomas (except kidney), particularly primary lung small cell carcinoma, and primary thyroid carcinoma.
Abstract: Context.—Differentiation of non–small cell carcinoma into histologic types is important because of new, successful therapies that target lung adenocarcinoma (ACA). TTF-1 is a favored marker for lun...

202 citations

Journal Article•DOI•
Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.

[...]

Kenneth Whithaus1, Junya Fukuoka2, Thomas J. Prihoda, Jaishree Jagirdar•
University of Texas Health Science Center at San Antonio1, University of Toyama2
30 Jan 2012-Archives of Pathology & Laboratory Medicine
TL;DR: The most cost-effective tissue-preserving panel for small biopsy specimens in the differential diagnosis of lung adenocarcinoma versus squamous cell carcinoma is a combination of p63 and napsin A.
Abstract: Context.—The distinction of lung adenocarcinoma from other types of primary lung malignancies is important clinically. Accurate morphologic classification is often hindered because 70% of lung canc...

111 citations